• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病急性复发的预测因素。一项实验室及临床研究。

Predictors of acute relapse of Crohn's disease. A laboratory and clinical study.

作者信息

Wright J P, Young G O, Tigler-Wybrandi N

出版信息

Dig Dis Sci. 1987 Feb;32(2):164-70. doi: 10.1007/BF01297104.

DOI:10.1007/BF01297104
PMID:3492346
Abstract

Relapses of Crohn's disease appear to be almost random. If these attacks could be reliably predicted, it might be possible to abort them with early treatment. In order to identify laboratory and clinical parameters that would predict an acute relapse, patients who had been assessed clinically in the three months prior to an attack were studied. Published clinical indices as well as variety of laboratory parameters were measured. The clinical indices and the serum C-reactive protein, orosomucoid, alpha 1-antitrypsin, and iron were increased at the time of the attack as compared to three months earlier, while only the clinical indices, orosomucoid and alpha 1-antitrypsin increased between three months and one month prior to the attack. There was a poor correlation of the parameters to each other. Further prospective studies are needed to determine the specificity of the suggested indices in predicting acute relapses of Crohn's disease.

摘要

克罗恩病的复发似乎几乎是随机的。如果能够可靠地预测这些发作,那么或许有可能通过早期治疗来阻止它们。为了确定能够预测急性复发的实验室和临床参数,对在发作前三个月接受过临床评估的患者进行了研究。测量了已发表的临床指标以及各种实验室参数。与三个月前相比,发作时临床指标以及血清C反应蛋白、类黏蛋白、α1抗胰蛋白酶和铁均升高,而在发作前三个月至一个月之间,只有临床指标、类黏蛋白和α1抗胰蛋白酶升高。这些参数之间的相关性较差。需要进一步的前瞻性研究来确定所建议指标在预测克罗恩病急性复发方面的特异性。

相似文献

1
Predictors of acute relapse of Crohn's disease. A laboratory and clinical study.克罗恩病急性复发的预测因素。一项实验室及临床研究。
Dig Dis Sci. 1987 Feb;32(2):164-70. doi: 10.1007/BF01297104.
2
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.结肠或回结肠型克罗恩病临床活动度、内镜严重程度与生物学参数之间的相关性。一项对121例病例的前瞻性多中心研究。消化系炎症性疾病治疗研究组。
Gut. 1994 Feb;35(2):231-5. doi: 10.1136/gut.35.2.231.
3
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.评估补充克罗恩病活动指数的适当实验室检测指标。
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
4
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
Gastroenterology. 1985 Jul;89(1):13-8. doi: 10.1016/0016-5085(85)90739-5.
5
A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.高血清白细胞介素-6浓度可预测静止期克罗恩病的复发。
Eur J Gastroenterol Hepatol. 1997 Oct;9(10):939-44. doi: 10.1097/00042737-199710000-00004.
6
Intestinal permeability test as a predictor of clinical course in Crohn's disease.肠道通透性测试作为克罗恩病临床病程的预测指标
Am J Gastroenterol. 1999 Oct;94(10):2956-60. doi: 10.1111/j.1572-0241.1999.01444.x.
7
Total parenteral nutrition modifies the acute phase response to Crohn's disease.
J R Coll Surg Edinb. 1994 Dec;39(6):360-4.
8
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.克罗恩病中白细胞介素-6持续产生的证据。
Gastroenterology. 1992 Feb;102(2):514-9. doi: 10.1016/0016-5085(92)90098-j.
9
[Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].[用于测定溃疡性结肠炎和克罗恩病疾病活动度的血清急性期蛋白]
Acta Med Austriaca. 1991;18(4):100-5.
10
Biological measurements of Crohn's disease activity--a reassessment.
Hepatogastroenterology. 1985 Jun;32(3):135-7.

引用本文的文献

1
Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy.生物治疗维持期克罗恩病患者的疾病转归与粪便钙卫蛋白水平的关联
Frontline Gastroenterol. 2014 Jul;5(3):167-175. doi: 10.1136/flgastro-2014-100441. Epub 2014 Apr 16.
2
Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.替代标志物在预测炎症性肠病复发中的应用。
J Gastroenterol. 2016 Jun;51(6):531-47. doi: 10.1007/s00535-016-1191-3. Epub 2016 Mar 14.
3
Current advantages in the application of proteomics in inflammatory bowel disease.

本文引用的文献

1
CROHN'S DISEASE OF THE LARGE INTESTINE.大肠克罗恩病
Gut. 1964 Dec;5(6):493-509. doi: 10.1136/gut.5.6.493.
2
An index of inflammatory activity in patients with Crohn's disease.克罗恩病患者的炎症活动指数。
Gut. 1980 Apr;21(4):279-86. doi: 10.1136/gut.21.4.279.
3
C-reactive protein levels in systemic lupus erythematosus: a classification criterion?系统性红斑狼疮中的C反应蛋白水平:一种分类标准?
当前在炎症性肠病中应用蛋白质组学的优势。
Dig Dis Sci. 2012 Nov;57(11):2755-64. doi: 10.1007/s10620-012-2291-4. Epub 2012 Jun 28.
4
Use of the Crohn's disease activity index in clinical trials of biological agents.克罗恩病活动指数在生物制剂临床试验中的应用。
World J Gastroenterol. 2008 Jul 14;14(26):4127-30. doi: 10.3748/wjg.14.4127.
5
Assessing disease activity and disease activity indices for inflammatory bowel disease.评估炎症性肠病的疾病活动度及疾病活动指数
Curr Gastroenterol Rep. 2002 Dec;4(6):490-6. doi: 10.1007/s11894-002-0025-z.
6
Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.α1-酸性糖蛋白在转基因小鼠中的过表达导致对急性结肠炎敏感。
Gut. 2002 Sep;51(3):398-404. doi: 10.1136/gut.51.3.398.
7
Non-invasive investigation of inflammatory bowel disease.炎症性肠病的非侵入性检查
World J Gastroenterol. 2001 Aug;7(4):460-5. doi: 10.3748/wjg.v7.i4.460.
8
Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease.肠道黏膜白细胞介素1β和白细胞介素-8的分泌可预测临床缓解期克罗恩病的复发。
Dig Dis Sci. 2001 Feb;46(2):402-9. doi: 10.1023/a:1005617302718.
9
Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.识别静止期克罗恩病复发高风险患者。GETAID研究组。消化系炎症性疾病治疗研究组。
Gut. 1995 Dec;37(6):811-8. doi: 10.1136/gut.37.6.811.
10
Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.
Dig Dis Sci. 1990 Feb;35(2):205-11. doi: 10.1007/BF01536764.
Arthritis Rheum. 1980 Jun;23(6):770-1. doi: 10.1002/art.1780230609.
4
Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel.
Gastroenterology. 1980 Jan;78(1):43-6.
5
Recent developments in nonspecific inflammatory bowel disease (second of two parts).非特异性炎症性肠病的最新进展(两部分中的第二部分)
N Engl J Med. 1982 Apr 8;306(14):837-48. doi: 10.1056/NEJM198204083061404.
6
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.评估补充克罗恩病活动指数的适当实验室检测指标。
Gut. 1981 Jul;22(7):571-4. doi: 10.1136/gut.22.7.571.
7
alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands.荷兰克罗恩病患者的α1-抗胰蛋白酶水平及表型
Gut. 1980 Oct;21(10):840-2. doi: 10.1136/gut.21.10.840.
8
Diagnostic usefulness of plasma carcinoembryonic antigen (CEA) levels in Crohn's disease.血浆癌胚抗原(CEA)水平在克罗恩病中的诊断价值
Dig Dis Sci. 1983 May;28(5):478-9. doi: 10.1007/BF02430539.
9
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎患者血清C反应蛋白水平
Eur J Clin Invest. 1982 Aug;12(4):351-9. doi: 10.1111/j.1365-2362.1982.tb02244.x.
10
Differential quantification of SIgA and SC by two-directional rocket method.采用双向火箭免疫电泳法对分泌型免疫球蛋白A(SIgA)和分泌片(SC)进行差异定量分析。
Immunology. 1980 Aug;40(4):597-604.